-
Je něco špatně v tomto záznamu ?
Cytotoxicity of acetylcholinesterase reactivators evaluated in vitro and its relation to their structure
L. Muckova, J. Pejchal, P. Jost, N. Vanova, D. Herman, D. Jun,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- alternativy testů na zvířatech MeSH
- buňky Hep G2 MeSH
- fibroblasty účinky léků MeSH
- inhibiční koncentrace 50 MeSH
- LD50 MeSH
- lidé MeSH
- molekulární struktura MeSH
- oximy chemie toxicita MeSH
- preklinické hodnocení léčiv MeSH
- reaktivátory cholinesterasy chemie toxicita MeSH
- viabilita buněk účinky léků MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
The development of acetylcholinesterase reactivators, i.e., antidotes against organophosphorus poisoning, is an important goal of defense research. The aim of this study was to compare cytotoxicity and chemical structure of five currently available oximes (pralidoxime, trimedoxime, obidoxime, methoxime, and asoxime) together with four perspective oximes from K-series (K027, K074, K075, and K203). The cytotoxicity of tested substances was measured using two methods - colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide assay and impedance based real-time cytotoxicity assay - in three different cell lines (HepG2, ACHN, and NHLF). Toxicity was subsequently expressed as toxicological index IC50. The tested compounds showed different cytotoxicity ranging from 0.92 to 40.06 mM. In HepG2 cells, K027 was the least and asoxime was the most toxic reactivator. In ACHN and NHLF cell lines, trimedoxime was the compound with the lowest adverse effects, whereas the highest toxicity was found in methoxime-treated cells. The results show that at least five structural features affect the reactivators' toxicity such as the number of oxime groups in the molecule, their position on pyridinium ring, the length of carbon linker, and the oxygen substitution or insertion of the double bond into the connection chain. Newly synthetized oximes with IC50 ≥ 1 mM evaluated in this three cell lines model might appear suitable for further testing.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028584
- 003
- CZ-PrNML
- 005
- 20190823092553.0
- 007
- ta
- 008
- 190813s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/01480545.2018.1432641 $2 doi
- 035 __
- $a (PubMed)29421945
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Muckova, Lubica $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic.
- 245 10
- $a Cytotoxicity of acetylcholinesterase reactivators evaluated in vitro and its relation to their structure / $c L. Muckova, J. Pejchal, P. Jost, N. Vanova, D. Herman, D. Jun,
- 520 9_
- $a The development of acetylcholinesterase reactivators, i.e., antidotes against organophosphorus poisoning, is an important goal of defense research. The aim of this study was to compare cytotoxicity and chemical structure of five currently available oximes (pralidoxime, trimedoxime, obidoxime, methoxime, and asoxime) together with four perspective oximes from K-series (K027, K074, K075, and K203). The cytotoxicity of tested substances was measured using two methods - colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide assay and impedance based real-time cytotoxicity assay - in three different cell lines (HepG2, ACHN, and NHLF). Toxicity was subsequently expressed as toxicological index IC50. The tested compounds showed different cytotoxicity ranging from 0.92 to 40.06 mM. In HepG2 cells, K027 was the least and asoxime was the most toxic reactivator. In ACHN and NHLF cell lines, trimedoxime was the compound with the lowest adverse effects, whereas the highest toxicity was found in methoxime-treated cells. The results show that at least five structural features affect the reactivators' toxicity such as the number of oxime groups in the molecule, their position on pyridinium ring, the length of carbon linker, and the oxygen substitution or insertion of the double bond into the connection chain. Newly synthetized oximes with IC50 ≥ 1 mM evaluated in this three cell lines model might appear suitable for further testing.
- 650 _2
- $a alternativy testů na zvířatech $7 D000826
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a reaktivátory cholinesterasy $x chemie $x toxicita $7 D002801
- 650 _2
- $a preklinické hodnocení léčiv $7 D004353
- 650 _2
- $a fibroblasty $x účinky léků $7 D005347
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inhibiční koncentrace 50 $7 D020128
- 650 _2
- $a LD50 $7 D007928
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a oximy $x chemie $x toxicita $7 D010091
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pejchal, Jaroslav $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic.
- 700 1_
- $a Jost, Petr $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic.
- 700 1_
- $a Vanova, Nela $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic.
- 700 1_
- $a Herman, David $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic.
- 700 1_
- $a Jun, Daniel $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic. b Biomedical Research Centre, University Hospital Hradec Kralove , Sokolska, Hradec Kralove , Czech Republic.
- 773 0_
- $w MED00001436 $t Drug and chemical toxicology $x 1525-6014 $g Roč. 42, č. 3 (2019), s. 252-256
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29421945 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190823092808 $b ABA008
- 999 __
- $a ok $b bmc $g 1433733 $s 1067044
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 42 $c 3 $d 252-256 $e 20180209 $i 1525-6014 $m Drug and chemical toxicology $n Drug Chem Toxicol $x MED00001436
- LZP __
- $a Pubmed-20190813